Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.22.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenue
Operating expenses    
Research and development 3,559,515 1,057,606
General and administrative 1,038,428 806,188
Total operating expenses 4,597,943 1,863,794
Loss from operations (4,597,943) (1,863,794)
Interest income 27,367 832
Net loss $ (4,570,576) $ (1,862,962)
Per share information:    
Net loss per common share, basic and diluted $ (0.35) $ (0.20)
Weighted average common shares outstanding, basic and diluted 12,944,134 9,499,155